Anti-Counterfeit Packaging Market Estimated to Reach Nearly $436 Million by 2030
Pharmaceutical Commerce
OCTOBER 17, 2023
Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.
Pharmaceutical Commerce
OCTOBER 17, 2023
Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.
Express Pharma
NOVEMBER 19, 2024
AGI Greenpac, a packaging products company in India, has received the Indian Green Building Council (IGBC) Platinum rating for its Specialty Glass Plant in Bhongir. These initiatives collectively position AGI Greenpac’s Specialty Glass Plant as a sustainability benchmark in the packaging products industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JANUARY 10, 2023
In 2024, Pharmapack Europe, the two-day exhibition and conference for pharma’s drug delivery and packaging industry will introduce two brand new zones to the flagship event. Bio packaging zone . Pharmapack’s bio packaging zone builds on its long history of being at the forefront of innovations in biological drug delivery.
Express Pharma
JULY 24, 2024
With a Rs 2,143 crore allocation under the Production Linked Incentive (PLI) scheme, India is set to lead globally in pharmaceuticals, with the domestic market projected to reach $ 130 billion by 2030. These steps are vital for achieving our $5 trillion GDP goal in three years and $7 trillion by 2030.
Express Pharma
NOVEMBER 29, 2023
It provides an unparalleled platform for stakeholders to participate in extensive dialogues covering pharma machinery, packaging, analytical instruments, laboratory technologies, equipment, ancillaries, ingredients, and beyond. Despite challenges in CIS countries, the global reception of Indian pharma remains positive.
Express Pharma
JANUARY 4, 2024
The Indian pharma industry is on a solid growth trajectory, surging from $40 billion in 2021 to an estimated $130 billion in 2030, with a steady double-digit CAGR for the next 10 years. In addition to meeting strong domestic demand, the Indian pharmaceutical industry is well poised as a robust contributor to the growing global market.
European Pharmaceutical Review
AUGUST 16, 2024
He is “confident” in Rayne’s ability to “execute towards our 2030 vision to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO ® ) antibody medicines”. Previously, Rayne held the role of Chief Operating Officer at Capsida Biotherapeutics.
Let's personalize your content